NCT04245969

Brief Summary

448kilohertz capacitive resistive monopolar radiofrequency is a novel technique in physiotherapy and its usefulness and clinical relevance is still to be investigated. Current studies show promising results in different musculoskeletal disorders, however further studies with proper designs and conclusive findings are necessary.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 29, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

March 30, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

January 29, 2020

Status Verified

January 1, 2020

Enrollment Period

2 months

First QC Date

October 15, 2019

Last Update Submit

January 26, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline ultrasound imaging at 3 months

    Elastography

    time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)

  • Change from Baseline ultrasound imaging at 3 months

    Tendon thickness

    time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)

Secondary Outcomes (8)

  • Electromyography

    time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)

  • Change from Baseline dynamometry at 3 months

    time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)

  • Algometry

    time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)

  • Range of movement

    time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)

  • Change from baseline SPADI (Shoulder Pain And Disability Index) questionnaire at three months

    time (t) 1(prior to treatment), t2 (immediately after the treatment), t3 (3 months later)

  • +3 more secondary outcomes

Study Arms (3)

INTERVENTION

EXPERIMENTAL

448 kilohertz Capacitive Resistive Monopolar Radiofrequency stimulus on the shoulder

Device: Experimental: 448 kilohertz Capacitive Resistive Monopolar Radiofrequency stimulus

Placebo Monopolar Radiofrequency stimulus

EXPERIMENTAL

To simulate the application of Monopolar Radiofrequency stimulus on the affected shoulder

Other: Sham comparator

No intervention group

EXPERIMENTAL

To evaluate at the same time than the others groups but without being treated with 448 kilohertz Capacitive Resistive Monopolar Radiofrequency.

Other: No intervention

Interventions

448kilohertz capacitive resistive monopolar radiofrequency will be applied on the shoulder and thoracic area

INTERVENTION

A simulation of 448kilohertz capacitive resistive monopolar radiofrequency will be carried out to make believe the patient to be treated through this equipment.

Placebo Monopolar Radiofrequency stimulus

These participants will be assessed at the same time than the rest of participants. They will not receive any kind of treatment.

No intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To suffer from shoulder pain more than three months.
  • Men or women aged between 18 to 65 years;
  • Unilateral pain located in the anterior and/or lateral shoulder region;
  • out of 3 positive clinical tests (Hawkins-Kennedy; Jobe; Neer);
  • Pain with normal activity ≥ 4/10 on a visual analogue scale;
  • Nontraumatic onset of shoulder pain.

You may not qualify if:

  • History of significant shoulder trauma, such as fracture or ultrasonography-clinically suspected full thickness cuff tear, following the classification of Wiener and Seitz
  • Recent shoulder dislocation in the past two years
  • Systemic illnesses such as rheumatoid arthritis
  • Adhesive capsulitis of the shoulder
  • Shoulder pain originating from the neck or if there was a neurological impairment, osteoporosis, hemophilia and/or malignancies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
UNIVERSITY PROFESSOR

Study Record Dates

First Submitted

October 15, 2019

First Posted

January 29, 2020

Study Start

March 30, 2020

Primary Completion

May 30, 2020

Study Completion

December 31, 2020

Last Updated

January 29, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share